OCGN Butterfly Strategy
OCGN (Ocugen, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.
OCGN (Ocugen, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $497.6M, a beta of 2.31 versus the broader market, a 52-week range of 0.64-2.725, average daily share volume of 9.0M, a public-listing history dating back to 2014, approximately 95 full-time employees. These structural characteristics shape how OCGN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 2.31 indicates OCGN has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a butterfly on OCGN?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
Current OCGN snapshot
As of May 15, 2026, spot at $1.38, ATM IV 102.80%, IV rank 23.32%, expected move 29.47%. The butterfly on OCGN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this butterfly structure on OCGN specifically: OCGN IV at 102.80% is on the cheap side of its 1-year range, which favors premium-buying structures like a OCGN butterfly, with a market-implied 1-standard-deviation move of approximately 29.47% (roughly $0.41 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated OCGN expiries trade a higher absolute premium for lower per-day decay. Position sizing on OCGN should anchor to the underlying notional of $1.38 per share and to the trader's directional view on OCGN stock.
OCGN butterfly setup
The OCGN butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With OCGN near $1.38, the first option leg uses a $1.31 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed OCGN chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 OCGN shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $1.31 | N/A |
| Sell 2 | Call | $1.38 | N/A |
| Buy 1 | Call | $1.45 | N/A |
OCGN butterfly risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
OCGN butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on OCGN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use butterfly on OCGN
Butterflies on OCGN are pinning bets - traders use them when they expect OCGN to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
OCGN thesis for this butterfly
The market-implied 1-standard-deviation range for OCGN extends from approximately $0.97 on the downside to $1.79 on the upside. A OCGN long call butterfly is a pinning play: it pays maximum at the middle strike if OCGN settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current OCGN IV rank near 23.32% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on OCGN at 102.80%. As a Healthcare name, OCGN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to OCGN-specific events.
OCGN butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. OCGN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move OCGN alongside the broader basket even when OCGN-specific fundamentals are unchanged. Always rebuild the position from current OCGN chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on OCGN?
- A butterfly on OCGN is the butterfly strategy applied to OCGN (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With OCGN stock trading near $1.38, the strikes shown on this page are snapped to the nearest listed OCGN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are OCGN butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the OCGN butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 102.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a OCGN butterfly?
- The breakeven for the OCGN butterfly priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current OCGN market-implied 1-standard-deviation expected move is approximately 29.47%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on OCGN?
- Butterflies on OCGN are pinning bets - traders use them when they expect OCGN to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current OCGN implied volatility affect this butterfly?
- OCGN ATM IV is at 102.80% with IV rank near 23.32%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.